Ashcroft G S, Lei K, Jin W, Longenecker G, Kulkarni A B, Greenwell-Wild T, Hale-Donze H, McGrady G, Song X Y, Wahl S M
Oral Infection and Immunity Branch, National Institute of Dental & Craniofacial Research, Building 30, 30 Convent Drive, MSC 4352, National Institutes of Health, Bethesda, Maryland 20892, USA.
Nat Med. 2000 Oct;6(10):1147-53. doi: 10.1038/80489.
Secretory leukocyte protease inhibitor (SLPI) is a serine protease inhibitor with anti-microbial properties found in mucosal fluids. It is expressed during cutaneous wound healing. Impaired healing states are characterized by excessive proteolysis and often bacterial infection, leading to the hypothesis that SLPI may have a role in this process. We have generated mice null for the gene encoding SLPI (Slpi), which show impaired cutaneous wound healing with increased inflammation and elastase activity. The altered inflammatory profile involves enhanced activation of local TGF-beta in Slpi-null mice. We propose that SLPI is a pivotal endogenous factor necessary for optimal wound healing.
分泌型白细胞蛋白酶抑制剂(SLPI)是一种存在于黏膜液中的具有抗微生物特性的丝氨酸蛋白酶抑制剂。它在皮肤伤口愈合过程中表达。愈合状态受损的特征是蛋白水解过度且常伴有细菌感染,这导致了SLPI可能在此过程中发挥作用的假设。我们已培育出编码SLPI(Slpi)的基因缺失的小鼠,这些小鼠表现出皮肤伤口愈合受损,炎症和弹性蛋白酶活性增加。Slpi基因缺失小鼠中改变的炎症特征涉及局部TGF-β的激活增强。我们提出,SLPI是最佳伤口愈合所必需的关键内源性因子。